Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

You may also like

Trading Halt

International Graphite (IG6:AU) has announced Trading Halt Download the PDF here. This post appeared first ...